CA3-AS1: A Drug Target / Disease Biomarker (G100996348)

Target Name: CA3-AS1

NCBI ID: G100996348

CA3-AS1

Other Name(s): CA3 antisense RNA 1, transcript variant 1 | CA3 antisense RNA 1 | CA3-AS1 variant 1

CA3-AS1: A Drug Target / Disease Biomarker

Cancer-associated protein 3 (CA3) is a protein that has been identified as a potential drug target or biomarker for various types of cancer. CA3 is a glycoprotein that is expressed in various tissues throughout the body, including the lungs, liver, and bones. It is known to play a role in cell signaling and has been linked to the development and progression of many types of cancer.

One of the key features of CA3 is its ability to interact with various signaling pathways, including the TGF-β pathway. This pathway is involved in many cellular processes, including cell growth, differentiation, and survival, and is a known target for many diseases, including cancer.

Research has shown that CA3 can interact with the TGF-β pathway and that this interaction may be important for the development and progression of cancer. One of the ways that CA3 does this is by regulating the activity of the transcription factor, Smad4.

Smad4 is a key transcription factor that is involved in many cellular processes, including cell growth, apoptosis, and inflammation. It has been shown to play a role in the development and progression of many types of cancer, including breast, lung, and colorectal cancers.

Research has also shown that CA3 can interact with the TGF-β pathway through the regulation of the activity of the protein, FGF17. FGF17 is a growth factor that is involved in cell growth and has been shown to play a role in the development and progression of many types of cancer.

In addition to its interaction with the TGF-β pathway, CA3 has also been shown to play a role in the development and progression of cancer through its effects on cell signaling pathways. For example, CA3 has been shown to interact with the protein, PDGFR-尾, which is involved in the development and progression of many types of cancer, including smartphones.

PDGFR-尾 is a transmembrane protein that is involved in cell signaling, including the development and progression of cancer. It has been shown to play a role in the development and progression of many types of cancer, including smartphones.

In conclusion, CA3 is a protein that has been shown to play a role in the development and progression of many types of cancer. Its interaction with the TGF-β pathway and other signaling pathways suggests that it may be a potential drug target or biomarker for cancer. Further research is needed to fully understand the role of CA3 in cancer development and progression.

Protein Name: CA3 Antisense RNA 1

The "CA3-AS1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CA3-AS1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets